A clinical study of UCB0107 for Progressive supranuclear palsy
Latest Information Update: 25 Feb 2020
At a glance
- Drugs Bepranemab (Primary)
- Indications Progressive supranuclear palsy
- Focus Therapeutic Use
Most Recent Events
- 25 Feb 2020 New trial record
- 19 Feb 2020 According to a UCB media release, the company aims to initiate an adequate and well controlled study in Q2 2020.